Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
4 hedge funds and large institutions have $1K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6% less capital invested
Capital invested by funds: $1.06K → $1K (-$60)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$60 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$28 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | +$31 | +565 | +1% |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| – | -$60 | -217,023 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$28 | -505 | -14% |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | +$5 | +100 | New |
|
PHIOW Hedge Fund Activity: Q4 2019 in Review
4 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q4 2019, worth a combined $1K — down 5.7% from $1.06K a quarter earlier.
Fund positioning in PHIOW was balanced in Q4 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $31. The largest seller was Anson Funds Management, exiting entirely with an estimated $60 sold.
- 4 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $1K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q4 2019, down 5.7% quarter-over-quarter.
- 1 fund opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q4 2019 and 1 closed out, a net change of 0 holders.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q4 2019 was Susquehanna International Group, an estimated $31 added.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q4 2019 was Anson Funds Management, an estimated $60 sold.
Based on aggregated 13F filings for Q4 2019.